Texas sues Sanofi over free nurse and support services kickback allegations
Texas Attorney General Ken Paxton has sued Sanofi-Aventis U.S. LLC, alleging that its Free Nurse Program and Support Services Program amounted to in-kind kickbacks to providers under the Texas Health Care Program Fraud Prevention Act. The state seeks more than $1 million in monetary relief, including civil penalties, and an injunction.
Texas Attorney General Ken Paxton filed a lawsuit against Sanofi-Aventis U.S. LLC, his office announced on February 19, 2026, alleging that the company provided illegal kickbacks to healthcare providers to encourage them to prescribe its drugs over alternatives. The state is seeking monetary relief of more than $1,000,000, including civil penalties, and an injunction to halt the alleged conduct.
The complaint centres on two Sanofi initiatives: a Free Nurse Program and a Support Services Program. The state alleges that providing nurse services and reimbursement support services to providers constituted in-kind remuneration in violation of the Texas Health Care Program Fraud Prevention Act, the state law governing fraud against Texas Medicaid and other state health programmes. Sanofi makes treatments for conditions including diabetes, multiple sclerosis, autoimmune disorders and haemophilia. The attorney general's office argues that because several of these drugs treat chronic illnesses, the alleged inducements created revenue streams lasting years, even where the prescribed drug may not have been the best option for the patient.
The attorney general's announcement did not include a response from Sanofi, and no public statement from the company was cited in the release.
The lawsuit is the latest in a series of Texas actions against drug manufacturers built on the same theory. In August 2025, Paxton sued Eli Lilly, alleging that free nurse services and reimbursement support offered to providers were illegal inducements tied to drugs including Mounjaro and Zepbound. In November 2025, his office sued Sanofi and Bristol-Myers Squibb under the same Texas statute over alleged failures to disclose that Plavix was less effective for certain patients. Patient support and hub services are widespread across the industry, and the Texas cases test whether state fraud statutes can treat those services as remuneration to prescribers rather than assistance to patients.
The case is at an early stage. The attorney general's announcement did not specify a trial date or the next procedural step, and no ruling in the matter had been reported.
Cite this report
The Precedent. "Texas sues Sanofi over free nurse and support services kickback allegations." September 1, 2026. https://theprecedent.org/article/texas-sues-sanofi-over-free-nurse-and-support-services-kickback-allegations
